Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?

被引:47
作者
Barrett, Emily S. [1 ]
Sobolewski, Marissa [2 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
Endocrine-disrupting chemicals; PCOS; BPA; Bisphenol A; EDCs; URINARY BISPHENOL-A; IN-UTERO EXPOSURE; UDP-GLUCURONOSYLTRANSFERASE; INSULIN-RESISTANCE; NEONATAL EXPOSURE; ANDROGEN EXCESS; ADIPOSE-TISSUE; BODY-WEIGHT; OBESITY; HORMONE;
D O I
10.1055/s-0034-1371088
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by multiple endocrine disturbances, and its underlying causes, although uncertain, are likely to be both genetic and environmental. Recently, there has been interest in whether endocrine-disrupting chemicals (EDCs) in the environment, particularly Bisphenol A (BPA), may contribute to the disorder. In animal models, exposure to BPA during the perinatal period dramatically disrupts ovarian and reproductive function in females, often at doses similar to typical levels of human exposure. BPA also appears to have obesogenic properties, disrupting normal metabolic activity and making the body prone to overweight. In humans, cross-sectional data suggest that BPA concentrations are higher in women with PCOS than in reproductively healthy women, but the direction of causality has not been established. As this research is in its infancy, additional work is needed to understand the mechanisms by which EDCs may contribute to PCOS as well as the critical periods of exposure, which may even be transgenerational. Future research should also focus on translating the promising work in animal models into longitudinal human studies and determining whether additional EDCs, beyond BPA, may be important to consider.
引用
收藏
页码:166 / 176
页数:11
相关论文
共 108 条
[51]   Dioxin (TCDD) Induces Epigenetic Transgenerational Inheritance of Adult Onset Disease and Sperm Epimutations [J].
Manikkam, Mohan ;
Tracey, Rebecca ;
Guerrero-Bosagna, Carlos ;
Skinner, Michael K. .
PLOS ONE, 2012, 7 (09)
[52]   In utero exposure to bisphenol a alters the development and tissue organization of the mouse mammary gland [J].
Markey, CM ;
Luque, EH ;
de Toro, MM ;
Sonnenschein, C ;
Soto, AM .
BIOLOGY OF REPRODUCTION, 2001, 65 (04) :1215-1223
[53]   Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs [J].
Markey, CM ;
Coombs, MA ;
Sonnenschein, C ;
Soto, AM .
EVOLUTION & DEVELOPMENT, 2003, 5 (01) :67-75
[54]   Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway [J].
Masuno, H ;
Iwanami, J ;
Kidani, T ;
Sakayama, K ;
Honda, K .
TOXICOLOGICAL SCIENCES, 2005, 84 (02) :319-327
[55]   Structural evidence for endocrine disruptor bisphenol a binding to human nuclear receptor ERRγ [J].
Matsushima, Ayami ;
Kakuta, Yoshimitsu ;
Teramoto, Takamasa ;
Koshiba, Takumi ;
Liu, Xiaohui ;
Okada, Hiroyuki ;
Tokunaga, Takatoshi ;
Kawabata, Shun-ichiro ;
Kimura, Makoto ;
Shimohigashi, Yasuyuki .
JOURNAL OF BIOCHEMISTRY, 2007, 142 (04) :517-524
[56]   Urinary Bisphenol A Concentration and Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women [J].
Melzer, David ;
Osborne, Nicholas J. ;
Henley, William E. ;
Cipelli, Riccardo ;
Young, Anita ;
Money, Cathryn ;
McCormack, Paul ;
Luben, Robert ;
Khaw, Kay-Tee ;
Wareham, Nicholas J. ;
Galloway, Tamara S. .
CIRCULATION, 2012, 125 (12) :1482-1490
[57]   Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06 [J].
Melzer, David ;
Rice, Neil E. ;
Lewis, Ceri ;
Henley, William E. ;
Galloway, Tamara S. .
PLOS ONE, 2010, 5 (01)
[58]   Genetic approaches to polycystic ovarian syndrome [J].
Menke, Marie Nam ;
Strauss, Jerome F., III .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (04) :355-359
[59]   Metabolic features of the reproductive phenotypes of polycystic ovary syndrome [J].
Moran, Lisa ;
Teede, Helena .
HUMAN REPRODUCTION UPDATE, 2009, 15 (04) :477-488
[60]   Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society [J].
Moran, Lisa J. ;
Pasquali, Renato ;
Teede, Helena J. ;
Hoeger, Kathleen M. ;
Norman, Robert J. .
FERTILITY AND STERILITY, 2009, 92 (06) :1966-1982